ZIVO BIOSCIENCE, INC. Deferred Tax Assets, Valuation Allowance
ZIVO BIOSCIENCE, INC. (ZIVO) had Deferred Tax Assets, Valuation Allowance of $13.73 million as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2025-03-18
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $13.73M.
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $12.38M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $10.79M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $9.09M; Deferred Tax Assets, Valuation Allowance as first filed $23.68M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2024-12-31 | $13.73M 10-K · filed 2025-03-18 | |
| 2023-12-31 | $12.38M 10-K · filed 2025-03-18 | |
| 2022-12-31 | $10.79M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $9.09M 10-K · filed 2023-03-14 | $23.68M 10-K · filed 2022-04-22 |
| 2020-12-31 | $21.16M 10-K · filed 2022-04-22 |